Revvity Announces Financial Results for the First Quarter of 2024

Go back to Revvity Announces Financial Results for the First Quarter of 2024

Revvity Inc (RVTY) PT Lowered to $120 at UBS

April 29, 2024 12:23 PM EDT

UBS analyst Dan Leonard lowered the price target on Revvity Inc (NYSE: RVTY) to $120.00 (from $125.00) while maintaining a Neutral rating.

The analyst comments "Q1 results came in ahead of expectation with 3% organic revenue decline, largely driven by stronger performance in Software, ImmunoDx and newborn... More